692 related articles for article (PubMed ID: 24954652)
21. Estimation of Detection Rates of Aneuploidy in High-Risk Pregnancy Using an Approach Based on Nuchal Translucency and Non-Invasive Prenatal Testing: A Cohort Study.
Khalil A; Mahmoodian N; Kulkarni A; Homfray T; Papageorghiou A; Bhide A; Thilaganathan B
Fetal Diagn Ther; 2015; 38(4):254-61. PubMed ID: 25925597
[TBL] [Abstract][Full Text] [Related]
22. From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan.
Shaw SW; Chen CP; Cheng PJ
Taiwan J Obstet Gynecol; 2013 Dec; 52(4):470-4. PubMed ID: 24411028
[TBL] [Abstract][Full Text] [Related]
23. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies.
Li R; Wan J; Zhang Y; Fu F; Ou Y; Jing X; Li J; Li D; Liao C
Ultrasound Obstet Gynecol; 2016 Jan; 47(1):53-7. PubMed ID: 26033469
[TBL] [Abstract][Full Text] [Related]
24. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
Chasen ST; McCullough LB; Chervenak FA
Am J Obstet Gynecol; 2004 Mar; 190(3):769-74. PubMed ID: 15042012
[TBL] [Abstract][Full Text] [Related]
25. Noninvasive prenatal testing for fetal trisomy in a mixed risk factors pregnancy population.
Li WH; Wang PH; Chuang CM; Chang YW; Yang MJ; Chen CY; Chao KC; Yen MS
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):122-5. PubMed ID: 25951714
[TBL] [Abstract][Full Text] [Related]
26. Non-invasive prenatal testing for aneuploidy: current status and future prospects.
Benn P; Cuckle H; Pergament E
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):15-33. PubMed ID: 23765643
[TBL] [Abstract][Full Text] [Related]
27. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss.
Caughey AB; Hopkins LM; Norton ME
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):612-6. PubMed ID: 16946222
[TBL] [Abstract][Full Text] [Related]
28. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age.
Nakata N; Wang Y; Bhatt S
Prenat Diagn; 2010 Mar; 30(3):198-206. PubMed ID: 20063323
[TBL] [Abstract][Full Text] [Related]
29. Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous?
Reiss RE; Discenza M; Foster J; Dobson L; Wilkins-Haug L
Prenat Diagn; 2017 May; 37(5):515-520. PubMed ID: 28326560
[TBL] [Abstract][Full Text] [Related]
30. The potential impact of NIPT as a second-tier screen on the outcomes of high-risk pregnancies with rare chromosomal abnormalities.
Maxwell S; Dickinson JE; Murch A; O'Leary P
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):420-6. PubMed ID: 26286670
[TBL] [Abstract][Full Text] [Related]
31. Non-invasive prenatal testing: impact on invasive prenatal diagnosis at a mainland Chinese tertiary medical center.
Li DZ; Zhen L; Pan M; Han J; Yang X; Ou YM
J Matern Fetal Neonatal Med; 2016 Nov; 29(21):3539-41. PubMed ID: 26743024
[TBL] [Abstract][Full Text] [Related]
32. First trimester contingent testing with either nuchal translucency or cell-free DNA. Cost efficiency and the role of ultrasound dating.
Conner P; Gustafsson S; Kublickas M
Acta Obstet Gynecol Scand; 2015 Apr; 94(4):368-75. PubMed ID: 25581307
[TBL] [Abstract][Full Text] [Related]
33. How do the trends in the prenatal diagnosis of aneuploidy change after a non-invasive prenatal test becomes available? A Japanese single center study.
Hasegawa J; Nakamura M; Sekizawa A
J Med Ultrason (2001); 2015 Apr; 42(2):195-8. PubMed ID: 26576572
[TBL] [Abstract][Full Text] [Related]
34. Prenatal diagnosis in twin gestations: a comparison between second-trimester amniocentesis and first-trimester chorionic villus sampling.
Wapner RJ; Johnson A; Davis G; Urban A; Morgan P; Jackson L
Obstet Gynecol; 1993 Jul; 82(1):49-56. PubMed ID: 8515925
[TBL] [Abstract][Full Text] [Related]
35. Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older.
Zoppi MA; Ibba RM; Putzolu M; Floris M; Monni G
Obstet Gynecol; 2001 Jun; 97(6):916-20. PubMed ID: 11384696
[TBL] [Abstract][Full Text] [Related]
36. National decline in invasive prenatal diagnostic procedures in association with uptake of combined first trimester and cell-free DNA aneuploidy screening.
Robson SJ; Hui L
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):507-10. PubMed ID: 26259499
[TBL] [Abstract][Full Text] [Related]
37. Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities.
Hume H; Chasen ST
Am J Obstet Gynecol; 2015 Oct; 213(4):545.e1-4. PubMed ID: 26070711
[TBL] [Abstract][Full Text] [Related]
38. Non-invasive prenatal testing for fetal aneuploidies in the first trimester of pregnancy.
Song Y; Huang S; Zhou X; Jiang Y; Qi Q; Bian X; Zhang J; Yan Y; Cram DS; Liu J
Ultrasound Obstet Gynecol; 2015 Jan; 45(1):55-60. PubMed ID: 25044397
[TBL] [Abstract][Full Text] [Related]
39. Uptake of fetal aneuploidy screening after the introduction of the non-invasive prenatal test: A national population-based register study.
van der Meij KRM; de Groot-van Mooren M; Carbo EWS; Pieters MJ; Rodenburg W; Sistermans EA; Cornel MC; Henneman L;
Acta Obstet Gynecol Scand; 2021 Jul; 100(7):1265-1272. PubMed ID: 33465829
[TBL] [Abstract][Full Text] [Related]
40. Chorionic villus sampling in the cell-free DNA aneuploidy screening era: careful selection criteria can maximise the clinical utility of screening and invasive testing.
Kane SC; Reidy KL; Norris F; Nisbet DL; Kornman LH; Palma-Dias R
Prenat Diagn; 2017 Apr; 37(4):399-408. PubMed ID: 28207933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
